Literature DB >> 34111337

Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy.

Ana Luz Galván-Díaz1, Juan Carlos Alzate2, Esteban Villegas3, Sofía Giraldo4, Jorge Botero5, Gisela García-Montoya6.   

Abstract

Cystoisospora belli is an intestinal Apicomplexan parasite associated with diarrheal illness and disseminated infections in humans, mainly immunocompromised individuals such as those living with the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS). An irregular administration of highly active antiretroviral therapy (HAART) in HIV patients may increase the risk of opportunistic infections like cystoisosporiasis. We describe here a case of C. belli infection in a Colombian HIV patient with chronic gastrointestinal syndrome and poor adherence to HAART. His clinical and parasitological cure was achieved with trimethoprim-sulfamethoxazole treatment. Although a reduction in the number of C. belli cases has been observed since the use of HAART, this parasite still has to be considered as a differential diagnosis of diarrheal disease in HIV/AIDS patients. Effective interventions enhancing adherence to HAART should be included in HIV patient care programs.

Entities:  

Keywords:  Apicomplexa; diarrhea; HIV; acquired immunodeficiency syndrome; antiretroviral therapy; highly active; Colombia

Year:  2021        PMID: 34111337      PMCID: PMC8318389          DOI: 10.7705/biomedica.5932

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  17 in total

Review 1.  Determination of the genera of cyst-forming coccidia.

Authors:  J K Frenkel; D D Smith
Journal:  Parasitol Res       Date:  2003-09-18       Impact factor: 2.289

2.  Developmental biology of Cystoisospora (Apicomplexa: Sarcocystidae) monozoic tissue cysts.

Authors:  David S Lindsay; Alice E Houk; Sheila M Mitchell; J P Dubey
Journal:  J Parasitol       Date:  2014-05-19       Impact factor: 1.276

Review 3.  Management of protease inhibitor-associated diarrhea.

Authors:  D S Sherman; D N Fish
Journal:  Clin Infect Dis       Date:  2000-06-14       Impact factor: 9.079

4.  [Frequency of intestinal microsporidian infections in HIV-positive patients, as diagnosis by quick hot Gram chromotrope staining and PCR].

Authors:  Jorge H Botero; Martha Nelly Montoya; Adriana Lucía Vanegas; Abel Díaz; Luis Navarro-i-Martínez; Fernando Jorge Bornay; Fernando Izquierdo; Carmen del Aguila; Sonia del Pilar Agudelo
Journal:  Biomedica       Date:  2004-12       Impact factor: 0.935

Review 5.  Cystoisospora belli infections in humans: the past 100 years.

Authors:  J P Dubey; S Almeria
Journal:  Parasitology       Date:  2019-08-09       Impact factor: 3.234

6.  Cystoisospora belli: in vitro multiplication in mammalian cells.

Authors:  M B Oliveira-Silva; E Lages-Silva; D V Resende; A Prata; L E Ramirez; J K Frenkel
Journal:  Exp Parasitol       Date:  2006-05-03       Impact factor: 2.011

Review 7.  Treatment of parasitic diarrhea in HIV-infected patients.

Authors:  Francis Derouin; Marie Lagrange-Xelot
Journal:  Expert Rev Anti Infect Ther       Date:  2008-06       Impact factor: 5.091

8.  Isosporiasis in patients with HIV infection in the highly active antiretroviral therapy era in France.

Authors:  M Lagrange-Xélot; R Porcher; C Sarfati; N de Castro; O Carel; J-D Magnier; V Delcey; J-M Molina
Journal:  HIV Med       Date:  2008-02       Impact factor: 3.180

9.  Cryptosporidium and other intestinal parasitic infections among HIV patients in southern Ethiopia: significance of improved HIV-related care.

Authors:  Techalew Shimelis; Yayehyirad Tassachew; Tariku Lambiyo
Journal:  Parasit Vectors       Date:  2016-05-10       Impact factor: 3.876

Review 10.  Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis.

Authors:  Ze-Dong Wang; Quan Liu; Huan-Huan Liu; Shuang Li; Li Zhang; Yong-Kun Zhao; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2018-01-09       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.